Bijul Pharmachem Private Limited

Bijul Pharmachem Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1991PTC061679 Incorporated 14 May 1991 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹4.51 Lakh
▼ 86% YoY
Net loss · FY 2025
₹27.65 Lakh
Latest filing
EBITDA · FY 2025
-₹2.2 Lakh
EBITDA margin -48.8%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹94.08 Lakh
Issued & subscribed
Satisfied charges
₹4.7 Cr
No open charges
Company age
35 yrs
Est. 1991
Directors on board
3
As per MCA filings

About Bijul Pharmachem Private Limited

Data last updated:

Bijul Pharmachem Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 14 May 1991 and has been in existence for over 35 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1991PTC061679. Its GSTIN is 27AABCB3518N2ZJ (Maharashtra). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹94.08 Lakh. It is led by directors including Shivam Rajiv Bohra and Ashutosh Rajiv Bohra.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 74/80 Babugenu Road Souribldg 3rd Floor Kalbadevi, Mumbai, Maharashtra, India – 400002.

As per the financials filed for FY 2025, the company reported a revenue of ₹4.51 Lakh, a decline of 86% compared to the previous year. For the same year it recorded a net loss of ₹27.65 Lakh and EBITDA of -₹2.2 Lakh (EBITDA margin -48.8%). Revenue has declined at a compounded annual rate (CAGR) of 41% over three years and 5% over five years.

As per MCA filings, the company has satisfied charges of ₹4.7 Cr on record. Court records list 1 case involving the company, including 1 filed by the company.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24230MH1991PTC061679
Registration Number 061679
Incorporation Date 14 May 1991
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Bijul Pharmachem Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    74/80 Babugenu Road Souribldg 3rd Floor Kalbadevi, Mumbai, Maharashtra, India – 400002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Bijul Pharmachem Private Limited, buy the company report.

Comprehensive company report
Bijul Pharmachem Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Bijul Pharmachem Private Limited

FY 2025 filings available

Bijul Pharmachem Private Limited reported revenue of ₹4.51 Lakh (down 86% YoY) for FY 2025.

Revenue · FY 2025
₹4.51 Lakh ▼ 86%
Net loss · FY 2025
₹27.65 Lakh
EBITDA · FY 2025
-₹2.2 Lakh margin -48.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 86%
3 years · compounded
▼ 41%
5 years · compounded
▼ 5%
EBITDA CAGR growth
1 year
▼ 108%
3 years · compounded
▲ 68%
5 years · compounded
▼ 99%

Revenue has declined at a compounded annual rate (CAGR) of 5% over five years, including a 86% fall in the latest year. EBITDA fell 108% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹2.2 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹27.65 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-48.8%
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Bijul Pharmachem Private Limited, buy the company report.

Board of directors of Bijul Pharmachem Private Limited

Bijul Pharmachem has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Shivam Rajiv BohraDirector14 Feb 20206 Years 8 MonthsCurrent
Ashutosh Rajiv BohraDirector10 Feb 20233 Years 8 MonthsCurrent
Rajiv Bijayshankar BohraDirector12 Nov 199134 Years 11 MonthsCurrent

Auditor

Bijul Pharmachem Private Limited is audited by PANSARI & DALMIA for the financial year 2021.

Auditor firmFinancial yearFirm registration number
PANSARI & DALMIAFY 2021107370W

Shareholding

The shareholding of Bijul Pharmachem Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Bijul Pharmachem Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹4.7 Cr
Breakdown by lending institutions
Uco Bank₹4.00 Cr
Uti Bank Limited₹0.70 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
29 Jun 200580048407Uti Bank Limited₹70 LakhSatisfied
14 May 200490187978Uco Bank₹4 CrSatisfied

To see the full charge records of Bijul Pharmachem Private Limited, buy the company report.

Total charge records: 2 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Bijul Pharmachem Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Bijul Pharmachem has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AABCB3518N2ZJMaharashtraActive21 Sep 2017

To see the full GST registrations and return filing status of Bijul Pharmachem Private Limited, buy the company report.

Recent activity

Bijul Pharmachem Private Limited has 8 board changes on record since 1991: 3 appointments and 5 cessations. The latest: Ashutosh Rajiv Bohra ceased to be Additional Director on 29 Sep 2023.

AGM
Bijul Pharmachem Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Bijul Pharmachem Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Ashutosh Rajiv Bohra ceased to be Additional Director.
Appointed
Ashutosh Rajiv Bohra was appointed as Director.
Ceased
Shivam Rajiv Bohra ceased to be Additional Director.
Appointed
Shivam Rajiv Bohra was appointed as Director.
Ceased
Mahesh Kumar Agarwal ceased to be Director.
Charges
A charge registered on 14 May 2004 via Charge ID 90187978 with Uco Bank was fully satisfied on 10 Feb 2009.
Charges
A charge registered on 29 Jun 2005 via Charge ID 80048407 with Uti Bank Limited was fully satisfied on 27 Aug 2008.
Ceased
Chandrashekhar Bijayshankar Bohra ceased to be Director.
Ceased
Bijoyshankar Chiranjilal Bohra ceased to be Director.
Charges
A charge with Uco Bank of Rs. 4.00 Cr registered on 14 May 2004 with Charge ID 90187978 was modified on 12 Jul 2007.

4 earlier events are in the company report.

Frequently asked questions

Bijul Pharmachem is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 14 May 1991 (35+ years old) and is registered under CIN U24230MH1991PTC061679.

Bijul Pharmachem has 3 current directors:

The latest financial statements of Bijul Pharmachem on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Bijul Pharmachem is 27AABCB3518N2ZJ, registered in Maharashtra. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Bijul Pharmachem is U24230MH1991PTC061679. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Bijul Pharmachem has 1 court case on record: 1 filed by the company.

Bijul Pharmachem was incorporated on 14 May 1991, making it 35+ years old. It is registered with the Registrar of Companies, Mumbai.

Ashutosh Rajiv Bohra ceased to be Additional Director on 29 Sep 2023. Ashutosh Rajiv Bohra was appointed as Director on 10 Feb 2023. Shivam Rajiv Bohra ceased to be Additional Director on 24 Oct 2020. Bijul Pharmachem has 8 board changes on record in total.

The registered office of Bijul Pharmachem is at 7480 Babugenu Road Souribldg 3rd Floor Kalbadevi, Mumbai, Maharashtra, India – 400002.

Bijul Pharmachem operates in the pharma industry, in the pharmaceutical retailers and distributors segment.